Cargando…
Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases
BACKGROUND: Data are limited regarding the effectiveness of omalizumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA). Our aim was to evaluate the clinical and functional effectiveness of omalizumab in patients with EGPA in long-term follow-up. METHODS: This study was a retros...
Autores principales: | Celebi Sozener, Zeynep, Gorgulu, Begum, Mungan, Dilsad, Sin, Betul Ayse, Misirligil, Zeynep, Aydin, Omur, Bavbek, Sevim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276141/ https://www.ncbi.nlm.nih.gov/pubmed/30524647 http://dx.doi.org/10.1186/s40413-018-0217-0 |
Ejemplares similares
-
Coincidence of pollen season and coronavirus disease 2019 pandemic: less time outdoors – lesser allergy symptoms in 2020
por: Sözener, Zeynep Çelebi, et al.
Publicado: (2021) -
Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA
por: Oiwa, Hiroshi, et al.
Publicado: (2017) -
Eosinophilic Granulomatosis with Polyangiitis (EGPA): A case report with atypical presentation
por: Mahmood, Khalid, et al.
Publicado: (2023) -
Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
por: Niccolai, Elena, et al.
Publicado: (2022) -
Allergen-specific immunotherapy practices and course of coronavirus disease 2019 (COVID-19) in patients during COVID-19
por: Erkoç, Merve, et al.
Publicado: (2022)